The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

secondary bone cancer

david200
david200 CSN Member Posts: 3
edited June 2018 in Breast Cancer #1
can anyone tell me if bone marrow transplant is good for someone with metastases in bones from breast cancer?
Like Care

Comments

  • 24242
    24242 CSN Member Posts: 1,398 *
    #2
    I have only heard of hodgkins lymphoma or non hodgkins can't remember which now have transplants and I have heard of breast cancer but don't know if they have had reoccurrance or not at the time. I don't know much but this.
    Tara
    Like Care
  • mc2001
    mc2001 CSN Member Posts: 343
    #3
    When I was in the leukemia ward, they had a woman with breast cancer who had a BMT. I am not sure why, however. This would be good to look into.
    -Michael
    Like Care
  • AuthorUnknown
    AuthorUnknown CSN Member Posts: 1,537 Member
    #4
    David:

    Although BMTs (bone marrow transplants) and SCTs (stem cell transplants) were widely deployed during late 80s and through much of the 90s, these therapies are rarely administered since then, in large part because, as Dr. Eric Winer, Director of the Breast Oncology Center out at the Dana-Farber Cancer Institute has correctly pointed out, more recent clinical evidence shows that comparable or superior outcomes are attainable with less radical and less toxic optimal endocrine (hormonal) therapies, often coupled with metastasis-slowing bisphosphonate therapy, and even advanced options like special radiopharmaceutical therapy, for example, Strontium-89 (Mateastron) and Samarium-153 (Quadramet), and coadministration of a COX-2 inhibitor with bisphosphonate therapy.

    ______________________________________________
    Constantine Kaniklidis
    Medical Researcher in EBM (Evidence-based Medicine)
    Breast Cancer Watch
    (http://breastcancer.evidencewatch.com)
    edge@evidencewatch.com
    Like Care

Discussion Boards